Author:
Mansouri Masoume,Nayebi Neda,keshtkar Abasali,Hasani-Ranjbar Shirin,Taheri Eghbal,Larijani Bagher
Abstract
Abstract
Background
The clustering of metabolic abnormalities defined as metabolic syndrome is now both a public health and a clinical problem .While interest in herbal medicine has greatly increased, lack of human evidence to support efficacies shown in animals does exist. This clinical trial study designed to investigate whether herbal medicine, Anethum graveolens (dill) extract, could improve metabolic components in patients with metabolic syndrome.
Methods
A double-blind, randomized, placebo-controlled trial using a parallel design was conducted. 24 subjects who had metabolic syndrome diagnostic criteria (update of ATP III) were randomly assigned to either dill extract (n = 12) or placebo (n = 12) for 3 months.
Results
Across lipid component of metabolic syndrome, no significant differences in triglyceride (TG) concentration and high density lipoprotein cholesterol were seen between the two groups. However TG improved significantly from baseline (257.0 vs. 201.5p = 0.01) with dill treatment but such a significant effect was not observed in placebo group. Moreover, no significant differences in waist circumference, blood pressure and fasting blood sugar were seen between two groups after 3 months follow up period.
Conclusion
In this small clinical trial in patients with metabolic syndrome, 12 weeks of dill extract treatment had a beneficial effect in terms of reducing TG from baseline. However dill treatment was not associated with a significant improvement in metabolic syndrome related markers compared to control group. Larger studies might be required to prove the efficacy and safety of long-term administration of dill to resolve metabolic syndrome components.
Publisher
Springer Science and Business Media LLC
Subject
Applied Mathematics,General Mathematics
Reference26 articles.
1. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006, 23 (5): 469-480. 10.1111/j.1464-5491.2006.01858.x.
2. Hasani-Ranjbar S, Larijani B, Abdollahi M: A systematic review of Iranian medicinal plants usefulin diabetes mellitus. Arch Med Sci. 2008, 4 (3): 285-292.
3. Yazdanparast R, Bahramikia S: Evaluation of the effect of Anethum graveolens L. crude extracts on serum lipids and lipoproteins profiles in hypercholesterolaemic rats. DARU. 2008, 16 (2): 88-94.
4. Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and International association for the study of obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.
5. Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, Heshmat R, Larijani B: Metabolic Syndrome and its Associated Risk Factors in Healthy Adults: Apopulation-based study in Iran. Metab Syndr Relat Disord. 2006, 4 (1): 28-34. 10.1089/met.2006.4.28.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献